AI assistant
Sending…
RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2019
Feb 15, 2019
30849_dirs_2019-02-15_feefd82a-2321-4d77-a1be-4177606294c8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2019-02-13
Reporting Person: Stewart Murray (Chief Medical Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-13 | Employee Stock Option (Right to Buy) | $29.78 | A | 60000 | Acquired | 2029-02-12 | Common Stock (60000) | Direct |
Footnotes
F1: This option was granted on February 13, 2019 and the shares underlying this option vest in sixteen equal quarterly installments beginning on May 13, 2019.
More from RHYTHM PHARMACEUTICALS, INC.
Registration Form
2026
May 5
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 3
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Mar 2